메뉴 건너뛰기




Volumn 25, Issue 4, 2004, Pages 366-377

Investigator and site selection and performing GCP clinical studies in India

Author keywords

Ethical; GCP clinical trials; India; Investigators selection; Regulatory; Site and hospital selection

Indexed keywords

ANALYSIS; ARTICLE; BUDGET; CLINICAL RESEARCH; CLINICAL STUDY; COST; GOOD CLINICAL PRACTICE; HUMAN; INDIA; INFORMATION PROCESSING; METHODOLOGY; QUALITY CONTROL;

EID: 3543031642     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2004.06.006     Document Type: Article
Times cited : (5)

References (36)
  • 1
    • 0029068463 scopus 로고
    • Managing research centers as a portfolio of strategic resources
    • Getz K.A., Fisher S.F., Brookman S. Managing research centers as a portfolio of strategic resources. Drug Inf. J. 29:1995;551-562
    • (1995) Drug Inf. J. , vol.29 , pp. 551-562
    • Getz, K.A.1    Fisher, S.F.2    Brookman, S.3
  • 2
    • 0029791311 scopus 로고    scopus 로고
    • Optimizing clinical site selection
    • McFarland L.V. Optimizing clinical site selection. Drug Inf. J. 30:1996;793-798
    • (1996) Drug Inf. J. , vol.30 , pp. 793-798
    • McFarland, L.V.1
  • 3
    • 0042196734 scopus 로고    scopus 로고
    • Why investigators take part in clinical trials
    • Glass H.E., Kane R.A. Why investigators take part in clinical trials. Appl. Clin. Trials. 2000 (June);46-54
    • (2000) Appl. Clin. Trials , pp. 46-54
    • Glass, H.E.1    Kane, R.A.2
  • 4
    • 3543003306 scopus 로고    scopus 로고
    • Best practices for site start-up and subject enrollment
    • Sietsema W.K. Best practices for site start-up and subject enrollment. Appl. Clin. Trials. 1999 (September);58-66
    • (1999) Appl. Clin. Trials , pp. 58-66
    • Sietsema, W.K.1
  • 5
    • 0037328623 scopus 로고    scopus 로고
    • Emergency medicine leadership in industry-sponsored clinical trials
    • Newgard C.D., Kim S., Camargo C.A. Emergency medicine leadership in industry-sponsored clinical trials. Acad. Emerg. Med. 10:2003;169-174
    • (2003) Acad. Emerg. Med. , vol.10 , pp. 169-174
    • Newgard, C.D.1    Kim, S.2    Camargo, C.A.3
  • 6
    • 0037116805 scopus 로고    scopus 로고
    • What to do about poor clinical performance in clinical trials
    • Mason S., Nicholl J., Lilford R. What to do about poor clinical performance in clinical trials. BMJ. 324:2002;419-421
    • (2002) BMJ , vol.324 , pp. 419-421
    • Mason, S.1    Nicholl, J.2    Lilford, R.3
  • 7
    • 0037608591 scopus 로고    scopus 로고
    • Selecting sites and investigators. An approach for Central and Eastern Europe
    • Demeter J. Selecting sites and investigators. An approach for Central and Eastern Europe. Appl. Clin. Trials. 2002 (March);56-65
    • (2002) Appl. Clin. Trials , pp. 56-65
    • Demeter, J.1
  • 8
    • 0031739048 scopus 로고    scopus 로고
    • Site selection for clinical trials
    • [Suppl.]
    • De Silva J. Site selection for clinical trials. Drug Inf. J. 32:1998;1257S-1258S. [Suppl.]
    • (1998) Drug Inf. J. , vol.32
    • De Silva, J.1
  • 9
    • 3543042275 scopus 로고    scopus 로고
    • Consider geography when choosing investigator sites
    • Schaub W. Consider geography when choosing investigator sites. Appl. Clin. Trials. 2002 (March);68-72
    • (2002) Appl. Clin. Trials , pp. 68-72
    • Schaub, W.1
  • 10
  • 11
    • 0035217053 scopus 로고    scopus 로고
    • The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): Clinical center recruitment experience
    • Wright J.T., et al. for the ALLHAT Research Group The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): clinical center recruitment experience. Control. Clin. Trials. 22:2001;659-673
    • (2001) Control. Clin. Trials , vol.22 , pp. 659-673
    • Wright, J.T.1
  • 12
    • 0344255785 scopus 로고    scopus 로고
    • Web-based decision support for clinical trial eligibility determination in an international clinical trials network
    • Breitfeld P.P, Ullrich F., Anderson J., Crist W.M. Web-based decision support for clinical trial eligibility determination in an international clinical trials network. Control. Clin. Trials. 24:2003;702-710
    • (2003) Control. Clin. Trials , vol.24 , pp. 702-710
    • Breitfeld, P.P.1    Ullrich, F.2    Anderson, J.3    Crist, W.M.4
  • 13
    • 0035666481 scopus 로고    scopus 로고
    • Carotid Revascularization with Endarterectomy or Stenting Systems (CARESS): Investigator selection
    • CARESS Steering Committee Carotid Revascularization with Endarterectomy or Stenting Systems (CARESS): investigator selection. J. Endovasc. Ther. 8:2001;547-549
    • (2001) J. Endovasc. Ther. , vol.8 , pp. 547-549
    • Steering Committee, C.1
  • 14
    • 1842488712 scopus 로고    scopus 로고
    • New drug discovery and development in India
    • [Supplement]
    • Maggon K. New drug discovery and development in India. Drug News Perspect. 16:2003;1-19. [Supplement]
    • (2003) Drug News Perspect. , vol.16 , pp. 1-19
    • Maggon, K.1
  • 15
  • 16
    • 3543044773 scopus 로고    scopus 로고
    • Role of CROs in new drug development
    • March 25
    • Maggon K. Role of CROs in new drug development. Express Pharma Pulse. 2004 (March 25);. [http://www.expresspharmapulse.com/20040325/editorial02.shtml]
    • (2004) Express Pharma Pulse
    • Maggon, K.1
  • 17
    • 3542993069 scopus 로고    scopus 로고
    • Clinical studies with new drugs: My Indian experiences
    • March 4
    • Maggon K. Clinical studies with new drugs: my Indian experiences. Express Pharma Pulse. 2004 (March 4);. [http://www.expresspharmapulse.com/20040304/ editorial02.shtml]
    • (2004) Express Pharma Pulse
    • Maggon, K.1
  • 18
    • 0037417529 scopus 로고    scopus 로고
    • Efficacy and cost-effectiveness of drug and psychological treatments for common mental disorders in general health care in Goa, India: A randomised, controlled trial
    • Patel V., Chisholm D.I., Rabe-Hesketh S., Dias-Saxena F., Andrew G., Mann A. Efficacy and cost-effectiveness of drug and psychological treatments for common mental disorders in general health care in Goa, India: a randomised, controlled trial. Lancet. 361:2003;33-39
    • (2003) Lancet , vol.361 , pp. 33-39
    • Patel, V.1    Chisholm, D.I.2    Rabe-Hesketh, S.3    Dias-Saxena, F.4    Andrew, G.5    Mann, A.6
  • 19
    • 0345130115 scopus 로고    scopus 로고
    • Clinical trial potential of academic centers in India
    • Bhandari M., Rao T.H.S.G., Kumar A. Clinical trial potential of academic centers in India. Transplant. Proc. 31:1999;1104-1105
    • (1999) Transplant. Proc. , vol.31 , pp. 1104-1105
    • Bhandari, M.1    Rao, T.H.S.G.2    Kumar, A.3
  • 20
  • 21
    • 1842540789 scopus 로고    scopus 로고
    • Global clinical trials in India - Challenges and opportunities
    • Bakhle D. Global clinical trials in India - challenges and opportunities. Business Briefing Pharmatech, Mumbai. 2003;109-110
    • (2003) Business Briefing Pharmatech, Mumbai , pp. 109-110
    • Bakhle, D.1
  • 22
    • 1842488717 scopus 로고    scopus 로고
    • Be clinical about trials
    • Mumbai, and 28 August
    • Sai, J.S., Be clinical about trials. Express Pharma Pulse Pharma Research, Mumbai, and 28 August 2003 [http://www.expresspharmapulse.com/ research.pdf].
    • (2003) Express Pharma Pulse Pharma Research
    • Sai, J.S.1
  • 24
    • 3543014197 scopus 로고    scopus 로고
    • Proposed changes in schedule Y - A step forward
    • 13 November
    • Bhatt A.D. Proposed changes in schedule Y - a step forward. Express Pharma Pulse. 2003 (13 November);. [http://www.expresspharmapulse.com/20031113/ pharmaexpo0303.shtml]
    • (2003) Express Pharma Pulse
    • Bhatt, A.D.1
  • 25
    • 3543000884 scopus 로고    scopus 로고
    • 2010. Indian clinical research odyssey
    • 26 February
    • Bhatt A., Sahoo U. 2010. Indian clinical research odyssey. Chron. Pharmabiz. 2004 (26 February);22-23
    • (2004) Chron. Pharmabiz , pp. 22-23
    • Bhatt, A.1    Sahoo, U.2
  • 26
    • 3543031446 scopus 로고    scopus 로고
    • CROs: Beneficial to Indian patients
    • January 2
    • Varawalla N.Y. CROs: beneficial to Indian patients. Express Pharma Pulse. 2004 (January 2);. [http://www.expresspharmapulse.com/20040101/editorial02. shtml]
    • (2004) Express Pharma Pulse
    • Varawalla, N.Y.1
  • 27
    • 0003962632 scopus 로고    scopus 로고
    • 29 January
    • Clinical trials in India Patient Capital Economist. 2000 (29 January);83-84
    • (2000) Economist , pp. 83-84
  • 29
    • 3542991887 scopus 로고    scopus 로고
    • Unending queue of unethical drug trials
    • February 29, 2004 and Express Pharma Pulse March 11
    • Gulhati, C.M., Unending queue of unethical drug trials. Monthly Index of Medical Specialities MIMS. February 29, 2004 and Express Pharma Pulse March 11, 2004 [http://www.expresspharmapulse.com/20040311/editorial02.shtml].
    • (2004) Monthly Index of Medical Specialities MIMS
    • Gulhati, C.M.1
  • 30
    • 0035944915 scopus 로고    scopus 로고
    • Johns Hopkins admits scientist used Indian patients as guinea pigs
    • 24 November
    • Mudur G. Johns Hopkins admits scientist used Indian patients as guinea pigs. Br. Med. J. 323:2001 (24 November);1204
    • (2001) Br. Med. J. , vol.323 , pp. 1204
    • Mudur, G.1
  • 31
    • 3543017145 scopus 로고    scopus 로고
    • India admits to unapproved drug formulations in market
    • 14 June
    • Mudur G. India admits to unapproved drug formulations in market. Br. Med. J. 326:2003 (14 June);1286
    • (2003) Br. Med. J. , vol.326 , pp. 1286
    • Mudur, G.1
  • 32
    • 3543029009 scopus 로고    scopus 로고
    • Monetary compensation attracts poor to drug trials
    • Ahmedabad. (13 September). .
    • Monetary compensation attracts poor to drug trials. The Times of India. Ahmedabad. 2002 (13 September). http://timesofindia.indiatimes.com/cms.dll/ articleshow?msid=22092939.
    • (2002) The Times of India
  • 33
    • 10744228833 scopus 로고    scopus 로고
    • Doctors in India prescribe unapproved fertility drug
    • Mudur G. Doctors in India prescribe unapproved fertility drug. Br. Med. J. 327:2003;768
    • (2003) Br. Med. J. , vol.327 , pp. 768
    • Mudur, G.1
  • 34
    • 3543000297 scopus 로고    scopus 로고
    • Unethical promotion in India
    • April 8
    • Maggon K. Unethical promotion in India. Express Pharma Pulse. 2004 (April 8);. [http://www.expresspharmapulse.com/20040408/editorial02.shtml]
    • (2004) Express Pharma Pulse
    • Maggon, K.1
  • 35
    • 3042621150 scopus 로고    scopus 로고
    • Comparative evaluation of the efficacy, safety, and tolerability of rosuvastatin 10 mg with atorvastatin 10 mg in adult patients with hypercholesterolaemia: The first Indian study
    • [
    • Jayaram S., Jain M.M., Naikawadi A.A., Gawde A., Desai A. Comparative evaluation of the efficacy, safety, and tolerability of rosuvastatin 10 mg with atorvastatin 10 mg in adult patients with hypercholesterolaemia: the first Indian study. JIMA. 101:2004;48-52. [http://www.jimaonline.org/january2004/ jan2004_Research%20Analysis%20Report.htm]
    • (2004) JIMA , vol.101 , pp. 48-52
    • Jayaram, S.1    Jain, M.M.2    Naikawadi, A.A.3    Gawde, A.4    Desai, A.5
  • 36
    • 1842454151 scopus 로고    scopus 로고
    • Marketing of medicines in India
    • Gulhati C.M. Marketing of medicines in India. BMJ. 328:2004;778-779
    • (2004) BMJ , vol.328 , pp. 778-779
    • Gulhati, C.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.